GENERAL CATALOGUE
DDO-2213
HY-153331 · 5 mg
MedChemExpress · Cat: HY-153331
₹120 – ₹180 approx.This price excludes freight and taxes. Please RFQ to get the final price.
Reach 3+ verified distributors
Manufacturer product page
medchemexpress.com/ddo-2213.html
Sponsored
Catalog No: HY-153331
CAS No: 2378768-36-4
Category: Epigenetics
Pack Size: 5 mg
Brand: MedChemExpress
Description
DDO-2213 is an orally active and potent WDR5-MLL1 inhibitor, with an IC50 of 29 nM and a Kd value of 72.9 nM for the WDR5 protein. DDO-2213 selectively inhibits MLL mixed lineage leukemia histone methyltransferase activity and the proliferation of MLL translocation-harboring cells. DDO-2213 can be used for MLL fusion leukemia research.
More from MedChemExpress
H
hsa-miR-4268 antagomir
HY-RI00947A
Epigenetics
H
hsa-miR-4731-5p antagomir
HY-RI01332A
Epigenetics
F
FRMD3 Human Pre-designed siRNA Set A
HY-RS05100
Epigenetics
M
MAPK12 Human Pre-designed siRNA Set A
HY-RS08101
Epigenetics
N
NEURL1 Human Pre-designed siRNA Set A
HY-RS09219
Epigenetics
L
LRFN2 Human Pre-designed siRNA Set A
HY-RS07782
Epigenetics
Luteolin 7-sulfate
HY-N6901
Epigenetics
VRTN Human Pre-designed siRNA Set A
HY-RS15705
Epigenetics